Tag Archives: artificial intelligence

Alpha Lifecare Partners with EchoCare to Introduce Cutting-Edge Remote Monitoring Solution for Elderly Care in Australia and New Zealand

Crestview, FL, 2024-May-15 — /EPR HEALTHCARE NEWS/ — EchoCare, a pioneer in remote monitoring solutions for eldercare and senior living, has appointed Alpha Lifecare as the exclusive distributor for its solution in Australia and New Zealand.

“EchoCare is delighted to be working with Alpha Lifecare as our exclusive distributor in the region to ensure that, as the use of our senior monitoring solution continues to expand, customers in Australia and New Zealand will be able to provide better and more efficient care to their clients. As Alpha Lifecare has one of the strongest footholds in the region for delivering world-class innovative technology to senior living providers to improve resident safety and experience, we look forward to building lasting relationships with customers in the region,” emphasized Rafi Zack, COO and acting CTO at EchoCare.

“We are sure that our partnership with EchoCare will enrich our solutions offerings to our customers, as the Digital Angel Radar, developed by EchoCare, offers the most accurate, non-wearable, monitoring solution available, facilitating early detection, targeted intervention, and effective prevention. The system is uniquely capable of monitoring both behaviours and vitals, without privacy-invading cameras and without requiring any action on the part of the older person. We are pleased to have deployed in a first customer site and look forward to rolling out the solution to many more,” said Luke Craddock, Director at Alpha Lifecare.

Explore further information on the Digital Angel Radar solution: https://alpha.global/fallpreventiondetection/

About EchoCare
EchoCare empowers senior living and care providers to enhance their service with around the clock monitoring for improved outcomes. The system learns the senior’s daily activities, facilitating recognition of changes in behaviour – both physical and cognitive – that might indicate increased risk of falls, or other abnormal situations. It also detects emergencies such as falls, wandering, or respiratory distress, which require an immediate response. The company operates globally, with a focus on the US and European markets.
https://echocare.ai/

About Alpha Lifecare
Alpha Lifecare has been delivering and defining solutions for senior care for over 40 years. Their mission is: We make lives better by caring further – helping more people, more often. The company’s technology division aims to deliver world-class innovative technology which improves resident safety and experience whilst also supporting facility teams in enhancing operational efficiencies.
https://alpha.global/

SOURCE: EPR Network

First patient enrolled in an international multicenter clinical study for non-invasive cardiac resynchronization therapy

BOLZANO/ BOZEN, Italy, 19-Mar-2023 — /EPR HEALTHCARE NEWS/ — XSpline SPA, a start-up company incorporated in Bolzano (Italy) and the Ordensklinikum Linz Elisabethinen Hospital in Linz (Austria) today announced the first patient enrolled in a clinical study (ClinicalTrials.govID: NCT05327062) for the cardiac resynchronization therapy (CRT) guided by non-invasive electrical and venous anatomy assessment.  The international multicenter prospective study will include 150 patients from 16 centers in the U.S. and Europe.

XSpline Cloud provides a cloud-based non-invasive cardiac panoramic mapping technology to select individual CRT treatment strategy and predict outcomes.

Fast and fully automatic Artificial Intelligence based epi- and endocardial segmentation of cardiac structures, including coronary sinus veins, provides clear understanding of individual patient’s anatomy. The electrical assessment is based on a 3D panoramic electro-anatomical map based on 12 -lead ECG only, without requiring multichannel ECG recording or any kind of body surface potential mapping. XSpline Cloud is the first system in the world with AI based identification of the correct target zone for LV lead implantation.

The cloud-platform guarantees full operability with existing clinical standards and data formats; it supports IHE profiles, HL7 FIHR, DICOM, and a broad range of ECG formats. The platform also provides embedded medical grade visualization tools, such as an integrated multimodality DICOM viewer, an ECG viewer with measurement capabilities, a high-performance 3D viewer for segmented cardiac structures and electro- anatomical maps as well as an interactive navigator for LV lead placement.

Dr. Georgios Kollias, M.D., is the principal investigator for the clinical trial in Austria and performed the first procedure on a 71-year-old patient with ESV LV of 154 ml and EF LV of 20%.

“The XSpline Cloud software provides a unique approach to selecting an individualized CRT treatment strategy. It is a comprehensive tool for successful CRT implantation that can also predict outcomes, making the implantation procedure faster, easier, and safer for the patient. We are very pleased to start using this tool in our clinic”, said Dr. Kollias.

“XSpline SPA is supported by an international R&D team of skilled clinicians, mathematicians, and biomedical engineers with the shared goal of improving patient care. We think that the real-time visualization of each patient’s individual anatomy, the precise non-invasive electro-anatomical endo- and epicardial activation map and the interactive navigator will help to increase CRT responders”, said Mr. Werner Rainer, CEO of the company.

XSpline Cloud is an investigational device and not yet approved for commercial use.

SOURCE: EuropaWire